Piera Maiolino

Micrornas in prostate cancer: an overview

Gerardo Botti, Michele Caraglia, G. Botti, 2017, Oncotarget.

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)

Antonella Petrillo, Vincenza Granata, Gerardo Botti, 2016, BMC Cancer.